LabConnect
The global provider of central laboratory and support services has named Dr. Anthony Todd Everhart to the position of medical director.
“In this new era of precision medicine, the role of the central laboratory is changing rapidly. Choosing a laboratory partner is no longer simply about a few dozen safety labs and a couple of data transfers. With the anticipated increase in gene editing and cell therapy research, the trials will be smaller, the study designs will be more complex, and the specimens collected will be more precious," said Everhart.
Speaking of his new role, he told us, "I will provide my clinical development, medical, and data analytics expertise to the continued growth and development of the unique service offerings required of the modern laboratory partner to successfully realize these innovative new therapies.”
Everhart was previously the vice president of medical informatics at Chiltern/Covance, vice president of medical affairs Americas at Chiltern, and medical director at Clinical Trial Management Services (CTMS).
He is board-certified in internal medicine and a fellow of the American College of Physicians.